Explore the revolutionary potential of precision medicine in this 58-minute World Economic Forum panel discussion. Delve into the challenges and opportunities presented by next-generation sequencing and CAR-T therapy as industry leaders address globalizing access, redesigning data governance, and navigating ethical complexities. Learn from experts representing the American Heart Association, Illumina, FDA, Novartis Pharma, and Singapore's Ministry of Health as they discuss topics such as data sharing, AI in healthcare, drug development, gene therapy, and equal access. Gain insights into the future of individualized treatments and their impact on healthcare systems worldwide.
Overview
Syllabus
Introduction
The expansion of precision medicine
Limitations of the data
Precision medicine
Data
Trust
Data Sharing
Continuous Learning
Affordability
Valuebased healthcare
AI
Why is it important to talk to the agency
The Marscan project
Social determinants of health
Drug development
Safety expectations
Partnerships
virtuous learning system
administrative challenges
data sharing culture
consumer managed health
clinical guidelines
lightning round
future state
gene therapy
equal access
change management
diagnostics
patient perspective
technology gap
Taught by
World Economic Forum
